These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16331288)

  • 41. Ventilatory effects of negative GABA(A) modulators in rhesus monkeys.
    Gerak LR; Estupinan LE; France CP
    Pharmacol Biochem Behav; 1998 Dec; 61(4):375-80. PubMed ID: 9802831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.
    Rudolph U; Knoflach F
    Nat Rev Drug Discov; 2011 Jul; 10(9):685-97. PubMed ID: 21799515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures.
    Deeb TZ; Maguire J; Moss SJ
    Epilepsia; 2012 Dec; 53 Suppl 9(0 9):79-88. PubMed ID: 23216581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physiological and pharmacological bases for the diverse properties of benzodiazepines and their congeners.
    Giusti P; Arban R
    Pharmacol Res; 1993 Apr; 27(3):201-15. PubMed ID: 8392172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenolics as GABA
    Ríos JL; Schinella GR; Moragrega I
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels.
    Te Beek ET; Chen X; Jacobs GE; Nahon KJ; de Kam ML; Lappalainen J; Cross AJ; van Gerven JM; Hay JL
    Clin Pharmacol Drug Dev; 2015 Mar; 4(2):149-54. PubMed ID: 27128218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.
    Engin E; Bakhurin KI; Smith KS; Hines RM; Reynolds LM; Tang W; Sprengel R; Moss SJ; Rudolph U
    Neuropsychopharmacology; 2014 Jul; 39(8):1805-15. PubMed ID: 24553732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of effective therapeutics targeting the GABAA receptor: naturally occurring alternatives.
    Tsang SY; Xue H
    Curr Pharm Des; 2004; 10(9):1035-44. PubMed ID: 15078131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of GABA(A) receptor subtypes as potential drug targets by using genetically modified mice.
    Rosahl TW
    Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):207-12. PubMed ID: 12871031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of GABA(A) receptors by natural products and the development of novel synthetic ligands for the benzodiazepine binding site.
    Nilsson J; Sterner O
    Curr Drug Targets; 2011 Oct; 12(11):1674-88. PubMed ID: 21561420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish.
    Bugel SM; Tanguay RL
    Toxicol Appl Pharmacol; 2018 Apr; 344():23-34. PubMed ID: 29499247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flavonoids as GABAA receptor ligands: the whole story?
    Wasowski C; Marder M
    J Exp Pharmacol; 2012; 4():9-24. PubMed ID: 27186113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.
    Colburn WA; Jack ML
    Clin Pharmacokinet; 1987 Sep; 13(3):179-90. PubMed ID: 2822333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroactive flavonoids interacting with GABAA receptor complex.
    Wang F; Shing M; Huen Y; Tsang SY; Xue H
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):575-85. PubMed ID: 16266290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The benzodiazepines and their receptors: 25 years of progress.
    Martin IL
    Neuropharmacology; 1987 Jul; 26(7B):957-70. PubMed ID: 2821436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and Abuse Liability of Oxazepam: Is This Benzodiazepine Drug Underutilized?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2016 Apr; 54(4):22-5. PubMed ID: 27042924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterocycles as physiological ligands for the benzodiazepine receptor and for other binding sites.
    Wildmann J
    Pharmacol Res; 1989; 21(6):673-82. PubMed ID: 2560546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stress and putative endogenous ligands for benzodiazepine receptors: the importance of characteristics of the aversive situation and of differential emotionality in experimental animals.
    Fernández-Teruel A; Escorihuela RM; Tobeña A; Driscoll P
    Experientia; 1991 Oct; 47(10):1051-6. PubMed ID: 1657629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rational approaches for the design of various GABA modulators and their clinical progression.
    Bhagat K; Singh JV; Pagare PP; Kumar N; Sharma A; Kaur G; Kinarivala N; Gandu S; Singh H; Sharma S; Bedi PMS
    Mol Divers; 2021 Feb; 25(1):551-601. PubMed ID: 32170466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions between porphyrins and mitochondrial benzodiazepine receptors.
    Kessel D
    Cancer Lett; 1988 Mar; 39(2):193-8. PubMed ID: 2834041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.